iRadimed Corporation (IRMD) — Analysis Summary
iRadimed Corporation (IRMD) has a market cap of $1.17B with year-over-year revenue growth of +14.4%. Net margin stands at 26.8%. The stock trades at a P/E ratio of 49.6.
Key Takeaways
- Revenue changed +14.4% year-over-year
- Net margin of 26.8%
- P/E ratio of 49.6
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, IRMD posted revenue growth of +14.4% and trades at a P/E of 49.6.
iRadimed Corporation (IRMD)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
166
Headquarters
ORLANDO, FL
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$0.80
Dividend Yield
0.87%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.